Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Valvular Heart Disease

Free Subscription Articles published in Heart Retrieve available abstracts of 251 articles: HTML format

Single Articles

April 2024
1. KUMAR M, Pettinato A, Ladha F, Earp JE, et al
   Sarcopenia and aortic valve disease.
   Heart. 2024 Apr 22:heartjnl-2024-324029. doi: 10.1136/heartjnl-2024-324029.
   PubMed     Abstract available
   
   
   March 2024
2. BIEROWSKI MJ, Warner ED, Edirisuriya CD
   Mitral valve dysfunction in a woman with newly diagnosed acute promyelocytic leukemia.
   Heart. 2024;110:507-540.
   PubMed    
   
   
   February 2024
3. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
   Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
   Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
   PubMed     Abstract available
   
   
   
4. TA S, Li J, Hsi DH, Hu R, et al
   Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up.
   Heart. 2024 Feb 22:heartjnl-2023-323606. doi: 10.1136/heartjnl-2023-323606.
   PubMed     Abstract available
   
   
   January 2024
5. WACHTELL K
   Understanding the driving mechanisms of bioprosthetic valve degeneration.
   Heart. 2024;110:223-224.
   PubMed    
   
   
   
6. GUAL-CAPLLONCH F, Pericas P
   Correspondence on 'Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation' by Lemarchand et al.
   Heart. 2024 Jan 18:heartjnl-2023-323697. doi: 10.1136/heartjnl-2023-323697.
   PubMed    
   
   
   December 2023
7. PATEL KP, McKenna M, Thornton GD, Vandermolen S, et al
   Predictors of outcome in patients with moderate mixed aortic valve disease.
   Heart. 2023 Dec 26:heartjnl-2023-323321. doi: 10.1136/heartjnl-2023-323321.
   PubMed     Abstract available
   
   
   
8. DELWARDE C, Toquet C, Boureau AS, Le Ruz R, et al
   Filamin A heart valve disease as a genetic cause of inherited bicuspid and tricuspid aortic valve disease.
   Heart. 2023 Dec 26:heartjnl-2023-323491. doi: 10.1136/heartjnl-2023-323491.
   PubMed     Abstract available
   
   
   
9. PAVON AG, Guglielmo M
   Carcinoid heart disease: another step into the knowledge of a rare disease.
   Heart. 2023;110:79-80.
   PubMed    
   
   
   
10. MONDAL S, Kumar SS, Kesavan V
    Case of presyncope with mitral regurgitation.
    Heart. 2023;110:18-74.
    PubMed    
    
    
    
11. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    PubMed     Abstract available
    
    
    
12. JANDER N, Minners J
    Towards a gender-specific and morphology-specific assessment of aortic valve stenosis severity.
    Heart. 2023 Dec 12:heartjnl-2023-323499. doi: 10.1136/heartjnl-2023-323499.
    PubMed    
    
    
    
13. SCARSINI R, Portolan L, Della Mora F, Fabroni M, et al
    Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.
    Heart. 2023 Dec 1:heartjnl-2023-323461. doi: 10.1136/heartjnl-2023-323461.
    PubMed     Abstract available
    
    
    November 2023
14. HAZEBROEK MR, Verdonschot JAJ
    One step closer to the new frontiers of healthcare for cardiomyopathy patients.
    Heart. 2023;109:1808-1810.
    PubMed    
    
    
    
15. ANDERSON RH, Spicer DE, Sanchez-Quintana D, Macias Y, et al
    Relationship between the aortic root and the atrioventricular conduction axis.
    Heart. 2023;109:1811-1818.
    PubMed     Abstract available
    
    
    
16. ANDERSON RH, Westaby J, Sheppard MN, Cook AC, et al
    Mitral annular disjunction: a ubiquitous finding with or without mitral valvar prolapse.
    Heart. 2023 Nov 24:heartjnl-2023-323501. doi: 10.1136/heartjnl-2023-323501.
    PubMed    
    
    
    
17. HEUTS S, Gabrio A, Veenstra L, Maesen B, et al
    Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
    Heart. 2023 Nov 23:heartjnl-2023-323359. doi: 10.1136/heartjnl-2023-323359.
    PubMed     Abstract available
    
    
    
18. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    PubMed     Abstract available
    
    
    
19. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    PubMed     Abstract available
    
    
    
20. KRAWCZYK-OZOG A, Batko J, Zdzierak B, Dziewierz A, et al
    Morphology of the mural and commissural atrioventricular junction of the mitral valve.
    Heart. 2023 Nov 7:heartjnl-2023-322965. doi: 10.1136/heartjnl-2023-322965.
    PubMed     Abstract available
    
    
    
21. TOMASELLI M, Badano LP, Muraru D
    Right atrial function, a mostly ignored but very valuable parameter in patients with secondary tricuspid regurgitation.
    Heart. 2023 Nov 6:heartjnl-2023-323426. doi: 10.1136/heartjnl-2023-323426.
    PubMed    
    
    
    
22. BOTEZATU SB, Yu X, Meah MN, Williams MC, et al
    Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis.
    Heart. 2023 Nov 2:heartjnl-2023-323217. doi: 10.1136/heartjnl-2023-323217.
    PubMed     Abstract available
    
    
    October 2023
23. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    PubMed     Abstract available
    
    
    
24. YE Z, Clavel MA, Foley TA, Pibarot P, et al
    Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology.
    Heart. 2023 Oct 30:heartjnl-2023-323281. doi: 10.1136/heartjnl-2023-323281.
    PubMed     Abstract available
    
    
    
25. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    PubMed     Abstract available
    
    
    
26. LEMARCHAND L, Auffret V, Le Breton H, Bedossa M, et al
    Echocardiographic estimation of pulmonary pressure in patients with severe tricuspid regurgitation.
    Heart. 2023 Oct 12:heartjnl-2023-322893. doi: 10.1136/heartjnl-2023-322893.
    PubMed     Abstract available
    
    
    
27. OTTO CM, Bartkowiak J, Hahn RT
    Right atrial pressure, not Doppler jet velocity, is the problem in estimating pulmonary pressure when tricuspid regurgitation is severe.
    Heart. 2023 Oct 12:heartjnl-2023-323230. doi: 10.1136/heartjnl-2023-323230.
    PubMed    
    
    
    
28. VEERARAGHAVAN S, Kidambi BR
    Sudden-onset breathlessness in a middle-aged man.
    Heart. 2023;109:1601-1650.
    PubMed    
    
    
    
29. DEMAL TJ, Conradi L
    Management of valve dysfunction in patients with mitral annular calcification.
    Heart. 2023;109:1639-1646.
    PubMed    
    
    
    September 2023
30. OTTO CM
    Heartbeat: a trend over the past 20 years towards decreased aortic stenosis mortality in patients aged 80 years or older.
    Heart. 2023;109:1419-1421.
    PubMed    
    
    
    
31. MICHELENA HI, Anand V, Enriquez-Sarano M, Pellikka PA, et al
    Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Ratwatte et al.
    Heart. 2023 Sep 1:heartjnl-2023-323347. doi: 10.1136/heartjnl-2023-323347.
    PubMed    
    
    
    
32. RATWATTE S, Celermajer DS
    Response to: Correspondence on 'Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes' by Michelena et al.
    Heart. 2023 Sep 1:heartjnl-2023-323348. doi: 10.1136/heartjnl-2023-323348.
    PubMed    
    
    
    August 2023
33. FARINA JM, Chao CJ, Pereyra M, Roarke M, et al
    Role of lipoprotein(a) concentrations in bioprosthetic aortic valve degeneration.
    Heart. 2023 Aug 29:heartjnl-2023-322987. doi: 10.1136/heartjnl-2023-322987.
    PubMed     Abstract available
    
    
    
34. BARNES C, Sharma H, Gamble J, Dawkins S, et al
    Management of secondary mitral regurgitation: from drugs to devices.
    Heart. 2023 Aug 22:heartjnl-2022-322001. doi: 10.1136/heartjnl-2022-322001.
    PubMed     Abstract available
    
    
    
35. JANG MH, Ahn JM, Kang DY, Kim KW, et al
    Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
    Heart. 2023 Aug 16:heartjnl-2023-322946. doi: 10.1136/heartjnl-2023-322946.
    PubMed     Abstract available
    
    
    
36. XU Z, Gong C, Chen Y
    Patient in their 40s with unexplained myocardial hypertrophy.
    Heart. 2023;109:1280-1340.
    PubMed    
    
    
    
37. OTTO CM
    Heartbeat: elevated pulmonary pressures in adults with aortic valve disease.
    Heart. 2023;109:1263-1265.
    PubMed    
    
    
    
38. KUSUNOSE K, Ikemiyagi H
    Prognostic implications of pulmonary vascular resistance in transcatheter aortic valve implantation.
    Heart. 2023 Aug 8:heartjnl-2023-323094. doi: 10.1136/heartjnl-2023-323094.
    PubMed    
    
    
    July 2023
39. LIEBENBERG J, Doubell A, Steyn J, Herbst P, et al
    Exploring the mechanisms responsible for reduced systolic function in high-gradient aortic stenosis.
    Heart. 2023 Jul 24:heartjnl-2023-322727. doi: 10.1136/heartjnl-2023-322727.
    PubMed     Abstract available
    
    
    
40. MASSERA D, Bartz TM, Biggs ML, Sotoodehnia N, et al
    Traditional and novel risk factors for incident aortic stenosis in community-dwelling older adults.
    Heart. 2023 Jul 18:heartjnl-2023-322709. doi: 10.1136/heartjnl-2023-322709.
    PubMed     Abstract available
    
    
    
41. MARTINSSON A, Torngren C, Nielsen SJ, Pan E, et al
    Renin-angiotensin system inhibition after surgical aortic valve replacement for aortic stenosis.
    Heart. 2023 Jul 17:heartjnl-2023-322922. doi: 10.1136/heartjnl-2023-322922.
    PubMed     Abstract available
    
    
    
42. LUMISH HS, Liang LW, Hasegawa K, Maurer MS, et al
    Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics.
    Heart. 2023 Jul 14:heartjnl-2023-322644. doi: 10.1136/heartjnl-2023-322644.
    PubMed     Abstract available
    
    
    
43. AFOKE J, Camacho E, Bagameri G
    Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
    Heart. 2023;109:1145-1192.
    PubMed    
    
    
    
44. FARRANT J, Dodd S, Vaughan C, Reid A, et al
    Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy.
    Heart. 2023;109:1175-1182.
    PubMed     Abstract available
    
    
    
45. CARDAIOLI F, Nai Fovino L, Fabris T, Masiero G, et al
    Updated definition of pulmonary hypertension and outcome after transcatheter aortic valve implantation.
    Heart. 2023 Jul 6:heartjnl-2023-322881. doi: 10.1136/heartjnl-2023-322881.
    PubMed     Abstract available
    
    
    
46. HOHMANN C, Pfister R, Frerker C, Beckmann A, et al
    Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
    Heart. 2023 Jul 5:heartjnl-2023-322548. doi: 10.1136/heartjnl-2023-322548.
    PubMed     Abstract available
    
    
    June 2023
47. NGUYEN DD, Arnold SV
    Impact of frailty on disease-specific health status in cardiovascular disease.
    Heart. 2023;109:977-983.
    PubMed     Abstract available
    
    
    
48. COURTNEY WA, Schultz CJ, Hillis GS
    Aortic valve calcification and outcomes in severe aortic stenosis.
    Heart. 2023 Jun 8:heartjnl-2023-322771. doi: 10.1136/heartjnl-2023-322771.
    PubMed    
    
    
    
49. CHOI Y, Ahn JM, Yang DH, Koo HJ, et al
    Clinical outcomes after aortic valve replacement with severe stenosis of trileaflet aortic valve and low valve calcium score.
    Heart. 2023 Jun 8:heartjnl-2023-322435. doi: 10.1136/heartjnl-2023-322435.
    PubMed     Abstract available
    
    
    
50. SAN ROMAN JA, Ybarra-Falcon C, Garcia-Gomez M, Ramos N, et al
    Recurrence of syncope after valve replacement in severe aortic stenosis.
    Heart. 2023 Jun 7:heartjnl-2023-322859. doi: 10.1136/heartjnl-2023-322859.
    PubMed     Abstract available
    
    
    May 2023
51. PISLARU SV, Nkomo VT
    Subannular repair for secondary mitral regurgitation: a step towards peaceful conversations.
    Heart. 2023 May 31:heartjnl-2023-322609. doi: 10.1136/heartjnl-2023-322609.
    PubMed    
    
    
    
52. NIENABER CA, Yuan X, Nienaber SA
    Aortic stenosis may not be fatal anymore in wealthy societies: but what about the rest of the world?
    Heart. 2023 May 26:heartjnl-2023-322737. doi: 10.1136/heartjnl-2023-322737.
    PubMed    
    
    
    
53. SEVILLA T, Rojas G, Gonzalez-Bartol E, Candela J, et al
    Magnetic resonance analysis of ventricular volumes in bicuspid and trileaflet aortic regurgitation.
    Heart. 2023 May 25:heartjnl-2023-322519. doi: 10.1136/heartjnl-2023-322519.
    PubMed     Abstract available
    
    
    
54. ANGUITA-GAMEZ M, Giraldo MA, Nombela-Franco L, Eixeres Esteve A, et al
    Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation.
    Heart. 2023 May 22:heartjnl-2022-322067. doi: 10.1136/heartjnl-2022-322067.
    PubMed     Abstract available
    
    
    
55. HIBINO M, Pandey AK, Hibino H, Verma R, et al
    Mortality trends of aortic stenosis in high-income countries from 2000 to 2020.
    Heart. 2023 May 19:heartjnl-2023-322397. doi: 10.1136/heartjnl-2023-322397.
    PubMed     Abstract available
    
    
    
56. OTTO CM
    Heartbeat: Choice of aortic valve intervention in younger adults.
    Heart. 2023;109:807-809.
    PubMed    
    
    
    
57. SHAH BN
    National Institute for Health and Care Excellence (NICE) guidance on heart valve disease.
    Heart. 2023;109:817-822.
    PubMed     Abstract available
    
    
    
58. VAN HOOF L, Lamberigts M, Noe D, El-Hamamsy I, et al
    Matched comparison between external aortic root support and valve-sparing root replacement.
    Heart. 2023;109:832-838.
    PubMed     Abstract available
    
    
    
59. NUNES MCP, Barbosa JAA, Mocumbi A
    Refining morphological echocardiographic criteria to improve early detection of rheumatic heart disease.
    Heart. 2023 May 12:heartjnl-2022-322325. doi: 10.1136/heartjnl-2022-322325.
    PubMed    
    
    
    
60. OH JK, Shen M, Guzzetti E, Tastet L, et al
    Effect of race on pressure recovery adjustment for prevention of aortic stenosis grading discordance.
    Heart. 2023 May 5:heartjnl-2023-322586. doi: 10.1136/heartjnl-2023-322586.
    PubMed     Abstract available
    
    
    
61. LEEDY D, Elison DM, Farias F, Cheng R, et al
    Transcatheter aortic valve intervention in patients with cancer.
    Heart. 2023 May 5:heartjnl-2022-321396. doi: 10.1136/heartjnl-2022-321396.
    PubMed     Abstract available
    
    
    
62. GALIAN-GAY L, Pijuan-Domenech A, Cantalapiedra-Romero J, Serrano B, et al
    Pregnancy-related aortic complications in women with bicuspid aortic valve.
    Heart. 2023 May 5:heartjnl-2022-322328. doi: 10.1136/heartjnl-2022-322328.
    PubMed     Abstract available
    
    
    
63. SAN ROMAN JA
    Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Paolisso et al.
    Heart. 2023 May 3:heartjnl-2023-322844. doi: 10.1136/heartjnl-2023-322844.
    PubMed    
    
    
    
64. VAN CAMP G
    Response to: Correspondence on "Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics" by Jose Alberto San Roman.
    Heart. 2023 May 3:heartjnl-2023-322845. doi: 10.1136/heartjnl-2023-322845.
    PubMed    
    
    
    April 2023
65. HUNTER LD, Doubell AF, Pecoraro AJK, Monaghan M, et al
    Morpho-mechanistic screening criteria for the echocardiographic detection of rheumatic heart disease.
    Heart. 2023 Apr 28:heartjnl-2022-322192. doi: 10.1136/heartjnl-2022-322192.
    PubMed     Abstract available
    
    
    
66. OTTO CM
    Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
    Heart. 2023;109:725-727.
    PubMed    
    
    
    
67. RUBIS P
    Low-normal systolic function and hypertrophic cardiomyopathy.
    Heart. 2023;109:732-733.
    PubMed    
    
    
    
68. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    PubMed     Abstract available
    
    
    
69. CRAMARIUC D, Urheim S
    Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
    Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
    PubMed    
    
    
    
70. RATWATTE S, Playford D, Stewart S, Strange G, et al
    Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322187. doi: 10.1136/heartjnl-2022-322187.
    PubMed     Abstract available
    
    
    
71. RATWATTE S, Stewart S, Strange G, Playford D, et al
    Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
    Heart. 2023 Apr 3:heartjnl-2022-322184. doi: 10.1136/heartjnl-2022-322184.
    PubMed     Abstract available
    
    
    March 2023
72. PAUSCH J, Harmel E, Reichenspurner H, Kempfert J, et al
    Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole.
    Heart. 2023 Mar 27:heartjnl-2022-322239. doi: 10.1136/heartjnl-2022-322239.
    PubMed     Abstract available
    
    
    
73. OTTO CM
    Heartbeat: heart valve clinics improve outcomes in patients with aortic valve stenosis.
    Heart. 2023;109:573-575.
    PubMed    
    
    
    
74. BISWAS A, Shukla A, Kothari SS
    Typical effort angina in a tall adult.
    Heart. 2023;109:605-650.
    PubMed    
    
    
    
75. GARTSHTEYN Y, Bhave N, Joseph MS, Askanase A, et al
    Inflammatory and thrombotic valvulopathies in autoimmune disease.
    Heart. 2023;109:583-588.
    PubMed     Abstract available
    
    
    
76. MARON MS, Rowin E, Spirito P, Maron BJ, et al
    Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
    Heart. 2023;109:589-594.
    PubMed     Abstract available
    
    
    
77. VELDERS BJJ, Vriesendorp MD, De Lind Van Wijngaarden RAF, Rao V, et al
    Perioperative care differences of surgical aortic valve replacement between North America and Europe.
    Heart. 2023 Mar 24:heartjnl-2023-322350. doi: 10.1136/heartjnl-2023-322350.
    PubMed     Abstract available
    
    
    
78. GEERS J, Bing R
    Computed tomographic imaging of patients with native and prosthetic aortic valve stenosis.
    Heart. 2023 Mar 22:heartjnl-2022-321660. doi: 10.1136/heartjnl-2022-321660.
    PubMed    
    
    
    
79. BEYER SE, Secemsky EA, Khabbaz K, Carroll BJ, et al
    Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort.
    Heart. 2023 Mar 16:heartjnl-2022-322033. doi: 10.1136/heartjnl-2022-322033.
    PubMed     Abstract available
    
    
    
80. ALI Z, Flynn AW
    Severe aortic stenosis and the need for the right treatment, in the right place, at the right time.
    Heart. 2023 Mar 13:heartjnl-2022-322195. doi: 10.1136/heartjnl-2022-322195.
    PubMed    
    
    
    
81. OTTO CM
    Heartbeat: clinical practice patterns for valve intervention in adults with aortic stenosis.
    Heart. 2023;109:495-497.
    PubMed    
    
    
    February 2023
82. KRIEGER EV, Burke CR, McCabe JM
    Sometimes mechanical, never routine: aortic valve replacement in young adults.
    Heart. 2023 Feb 27:heartjnl-2022-322150. doi: 10.1136/heartjnl-2022-322150.
    PubMed    
    
    
    
83. STOICA S, Beard C, Takkenberg JJM, Mokhles MM, et al
    Formal consensus study on surgery to replace the aortic valve in adults aged 18-60 years.
    Heart. 2023 Feb 27:heartjnl-2022-321740. doi: 10.1136/heartjnl-2022-321740.
    PubMed     Abstract available
    
    
    
84. DREYFUS J, Bohbot Y, Coisne A, Lavie-Badie Y, et al
    Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery.
    Heart. 2023 Feb 24:heartjnl-2022-322167. doi: 10.1136/heartjnl-2022-322167.
    PubMed     Abstract available
    
    
    
85. HANNA EB, Vutthikraivit W
    Progressive dyspnoea in a patient with neuroendocrine tumor: do invasive haemodynamics help?
    Heart. 2023;109:348-416.
    PubMed    
    
    
    
86. RUMMAN RK, Verma S, Chan V, Mazer D, et al
    Predictors of mitral valve haemodynamics after mitral valve repair for degenerative mitral regurgitation.
    Heart. 2023 Feb 7:heartjnl-2022-321753. doi: 10.1136/heartjnl-2022-321753.
    PubMed     Abstract available
    
    
    January 2023
87. OTTO CM
    Heartbeat: not all patients with primary mitral regurgitation are the same.
    Heart. 2023;109:245-247.
    PubMed    
    
    
    
88. LI J, Zhang J, Shi Y, Sievert H, et al
    Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation.
    Heart. 2023;109:289-296.
    PubMed     Abstract available
    
    
    
89. IUNG B, Banovic M
    Added value of heart valve clinics in the management of asymptomatic aortic stenosis.
    Heart. 2023 Jan 26:heartjnl-2022-322101. doi: 10.1136/heartjnl-2022-322101.
    PubMed    
    
    
    
90. RUDOLPH TK, Messika-Zeitoun D, Frey N, Lutz M, et al
    Severe aortic stenosis management in heart valve centres compared with primary/secondary care centres.
    Heart. 2023 Jan 19:heartjnl-2022-321566. doi: 10.1136/heartjnl-2022-321566.
    PubMed     Abstract available
    
    
    
91. PATEL KP, Baumbach A
    Future of transcatheter aortic valve implantation: where do we go from here?
    Heart. 2023 Jan 11:heartjnl-2022-321575. doi: 10.1136/heartjnl-2022-321575.
    PubMed    
    
    
    December 2022
92. HAHN RT
    Understanding the anatomy of the mitral valve: attitudinal is unnecessary.
    Heart. 2022 Dec 30:heartjnl-2022-322236. doi: 10.1136/heartjnl-2022-322236.
    PubMed    
    
    
    
93. ANDERSON RH, Garbi M, Zugwitz D, Petersen SE, et al
    Anatomy of the mitral valve relative to controversies concerning the so-called annular disjunction.
    Heart. 2022 Dec 30:heartjnl-2022-322043. doi: 10.1136/heartjnl-2022-322043.
    PubMed     Abstract available
    
    
    
94. MECCANICI F, Schotte MH, Snoeren M, Bons LR, et al
    Aortic dilation and growth in women with Turner syndrome.
    Heart. 2022;109:102-110.
    PubMed     Abstract available
    
    
    
95. ANDROSHCHUK V, Patterson T, Redwood SR
    Management of coronary artery disease in patients with aortic stenosis.
    Heart. 2022 Dec 16:heartjnl-2022-321605. doi: 10.1136/heartjnl-2022-321605.
    PubMed     Abstract available
    
    
    
96. DI FUSCO SA, Arca M, Scicchitano P, Alonzo A, et al
    Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target.
    Heart. 2022;109:18-25.
    PubMed     Abstract available
    
    
    
97. SCARSINI R, Pighi M, Mainardi A, Portolan L, et al
    Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis.
    Heart. 2022 Dec 13:heartjnl-2022-321907. doi: 10.1136/heartjnl-2022-321907.
    PubMed     Abstract available
    
    
    
98. PAOLISSO P, Beles M, Belmonte M, Gallinoro E, et al
    Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics.
    Heart. 2022 Dec 12:heartjnl-2022-321874. doi: 10.1136/heartjnl-2022-321874.
    PubMed     Abstract available
    
    
    
99. GRAVERSEN PL, Butt JH, Ostergaard L, Jensen AD, et al
    Changes in aortic valve replacement procedures in Denmark from 2008 to 2020.
    Heart. 2022 Dec 5:heartjnl-2022-321594. doi: 10.1136/heartjnl-2022-321594.
    PubMed     Abstract available
    
    
    
100. PARADIES V, Mamas MA
     Aortic valve treatment: from the first aortic valve replacement to the last decade of revolution.
     Heart. 2022 Dec 5:heartjnl-2022-321933. doi: 10.1136/heartjnl-2022-321933.
     PubMed    
     
     
     November 2022
101. DONAL E, Yamada H
     Do not underestimate the impact of load and of remodelling capabilities of the right heart.
     Heart. 2022;108:1926-1927.
     PubMed    
     
     
     
102. GATI S, Sharma S
     Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know.
     Heart. 2022;108:1930-1937.
     PubMed     Abstract available
     
     
     
103. BURSI F, Lee AP
     Strain and mitral regurgitation: is atrial functional mitral regurgitation a ventricular disease?
     Heart. 2022 Nov 11. pii: heartjnl-2022-321945. doi: 10.1136/heartjnl-2022-321945
     PubMed    
     
     
     
104. OTTO CM
     Heartbeat: valve-sparing root replacement comes of age.
     Heart. 2022;108:1835-1837.
     PubMed    
     
     
     
105. KUSUNOSE K
     Insights of pressure-flow relationship during exercise in cardiovascular diseases.
     Heart. 2022;108:1841-1842.
     PubMed    
     
     
     
106. ANDERSEN MJ, Wolsk E, Bakkestrom R, Christensen N, et al
     Pressure-flow responses to exercise in aortic stenosis, mitral regurgitation and diastolic dysfunction.
     Heart. 2022;108:1895-1903.
     PubMed     Abstract available
     
     
     
107. ANTONOVA P, Rohn V, Chaloupecky V, Simkova I, et al
     Predictors of mortality after atrial correction of transposition of the great arteries.
     Heart. 2022;108:1881-1886.
     PubMed     Abstract available
     
     
     
108. DAVID T
     Outcomes of aortic root replacement.
     Heart. 2022;108:1838.
     PubMed    
     
     
     
109. SPRACKLEN TF, Keavney B, Laing N, Ntusi N, et al
     Modern genomic techniques in the identification of genetic causes of cardiomyopathy.
     Heart. 2022;108:1843-1850.
     PubMed     Abstract available
     
     
     October 2022
110. LIANG LW, Raita Y, Hasegawa K, Fifer MA, et al
     Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.
     Heart. 2022;108:1807-1814.
     PubMed     Abstract available
     
     
     
111. MEUCCI MC, Stassen J, Tomsic A, Palmen M, et al
     Prognostic impact of left ventricular global longitudinal strain in atrial mitral regurgitation.
     Heart. 2022 Oct 21. pii: heartjnl-2022-321698. doi: 10.1136/heartjnl-2022-321698
     PubMed     Abstract available
     
     
     
112. MESSIKA-ZEITOUN D, Chan V, Burwash IG
     Latent class analysis to predict outcomes after surgery for primary mitral regurgitation: a scientific validation of common sense.
     Heart. 2022 Oct 21. pii: heartjnl-2022-321555. doi: 10.1136/heartjnl-2022-321555
     PubMed    
     
     
     
113. OTTO CM
     Heartbeat: medical therapy, not just mechanical intervention, for optimal outcomes in patients with secondary mitral regurgitation.
     Heart. 2022;108:1665-1667.
     PubMed    
     
     
     
114. ALHARETHI R, Butschek RA, Rasmusson K, Whisenant BK, et al
     The synergy of myopathic valvular disease.
     Heart. 2022;108:1670-1671.
     PubMed    
     
     
     
115. COSTA GNF, Cardoso JFL, Oliveiros B, Goncalves L, et al
     Early surgical intervention versus conservative management of asymptomatic severe aortic stenosis: a systematic review and meta-analysis.
     Heart. 2022 Oct 5. pii: heartjnl-2022-321411. doi: 10.1136/heartjnl-2022-321411.
     PubMed     Abstract available
     
     
     September 2022
116. NAGUEH SF
     Sex and outcomes after alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy.
     Heart. 2022;108:1588-1589.
     PubMed    
     
     
     
117. LAWIN D, Lawrenz T, Marx K, Danielsmeier NB, et al
     Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
     Heart. 2022;108:1623-1628.
     PubMed     Abstract available
     
     
     
118. MAPELLI M, Romani S, Magri D, Merlo M, et al
     Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy.
     Heart. 2022;108:1629-1636.
     PubMed     Abstract available
     
     
     
119. MILLAR LM, Lloyd G, Bhattacharyya S
     Care of the patient after valve intervention.
     Heart. 2022;108:1516-1523.
     PubMed     Abstract available
     
     
     
120. DEJA MA
     Aortic valve cusp prolapse before and after valve-sparing aortic root replacement.
     Heart. 2022 Sep 9. pii: heartjnl-2022-321390. doi: 10.1136/heartjnl-2022-321390.
     PubMed    
     
     
     
121. GWAK SY, Ko KY, Cho I, Hong GR, et al
     Risk factors and outcomes with surgical bioprosthetic mitral valve dysfunction.
     Heart. 2022 Sep 6. pii: heartjnl-2022-321307. doi: 10.1136/heartjnl-2022-321307.
     PubMed     Abstract available
     
     
     August 2022
122. CARBERRY J, Ang D, Berry C
     Coronary blood flow and severe aortic stenosis.
     Heart. 2022 Aug 25. pii: heartjnl-2022-321587. doi: 10.1136/heartjnl-2022-321587
     PubMed    
     
     
     
123. CURKOVIC NB, Clark DE, Hughes SG
     Syncope in an elderly man with hypertrophic obstructive cardiomyopathy.
     Heart. 2022;108:1437-1500.
     PubMed    
     
     
     
124. WILDE N, Rogmann M, Mauri V, Piayda K, et al
     Haemodynamic differences between two generations of a balloon-expandable transcatheter heart valve.
     Heart. 2022;108:1479-1485.
     PubMed     Abstract available
     
     
     
125. PAOLISSO P, Gallinoro E, Vanderheyden M, Esposito G, et al
     Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis.
     Heart. 2022 Aug 17. pii: heartjnl-2022-321348. doi: 10.1136/heartjnl-2022-321348
     PubMed     Abstract available
     
     
     
126. KASSIS N, Hariri E, Kapadia S
     Response to: Rapid response by Diehl on 'Supplemental calcium and vitamin D and long-term mortality in aortic stenosis'.
     Heart. 2022;108:1415.
     PubMed    
     
     
     
127. ZAIDI AN
     Tetralogy of Fallot: management of residual hemodynamic and electrophysiological abnormalities.
     Heart. 2022;108:1408-1414.
     PubMed    
     
     
     July 2022
128. KIM M, Lee PH, Kim DH, Jung SH, et al
     Transcatheter versus surgical closure of atrial septal defect in adult patients with tricuspid regurgitation.
     Heart. 2022 Jul 29. pii: heartjnl-2022-321225. doi: 10.1136/heartjnl-2022-321225
     PubMed     Abstract available
     
     
     
129. LAFLAMME E, Wald RM, Roche SL, Silversides CK, et al
     Outcome and right ventricle remodelling after valve replacement for pulmonic stenosis.
     Heart. 2022;108:1290-1295.
     PubMed     Abstract available
     
     
     
130. KWAK S, Lee SA, Lim J, Yang S, et al
     Long-term outcomes in distinct phenogroups of patients with primary mitral regurgitation undergoing valve surgery.
     Heart. 2022 Jul 26. pii: heartjnl-2022-321305. doi: 10.1136/heartjnl-2022-321305
     PubMed     Abstract available
     
     
     
131. PROKSELJ K, Brida M
     Atrial switch operation for transposition of the great arteries: tricuspid regurgitation matters.
     Heart. 2022 Jul 18. pii: heartjnl-2022-321398. doi: 10.1136/heartjnl-2022-321398
     PubMed    
     
     
     
132. VILALTA V, Cediel G, Mohammadi S, Lopez H, et al
     New-onset persistent left bundle branch block following sutureless aortic valve replacement.
     Heart. 2022 Jul 16. pii: heartjnl-2022-321191. doi: 10.1136/heartjnl-2022-321191
     PubMed     Abstract available
     
     
     
133. EHRLICH T, Hagendorff A, Abeln K, Froede L, et al
     Aortic cusp abnormalities in patient with trileaflet aortic valve and root aneurysm.
     Heart. 2022 Jul 8. pii: heartjnl-2022-320905. doi: 10.1136/heartjnl-2022-320905.
     PubMed     Abstract available
     
     
     June 2022
134. YALTA K, Yalta T, Ozturk C
     Correspondence on "Tetralogy of Fallot: management of residual hemodynamic and electrophysiological abnormalities" by Zaidi.
     Heart. 2022;108:1157.
     PubMed    
     
     
     
135. MEIJS TA, Muller SA, Minderhoud SCS, de Winter RJ, et al
     Hypertensive response to exercise in adult patients with repaired aortic coarctation.
     Heart. 2022;108:1121-1128.
     PubMed     Abstract available
     
     
     
136. HAEFFELE C
     Adult congenital heart disease: left-sided obstructive lesions.
     Heart. 2022;108:1148-1156.
     PubMed    
     
     
     
137. WACHTELL K
     The sweet development and progression of aortic stenosis.
     Heart. 2022 Jun 23. pii: heartjnl-2022-321331. doi: 10.1136/heartjnl-2022-321331
     PubMed    
     
     
     
138. COISNE A, Montaigne D, Ninni S, Lamblin N, et al
     Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis.
     Heart. 2022 Jun 13. pii: heartjnl-2022-320897. doi: 10.1136/heartjnl-2022-320897
     PubMed     Abstract available
     
     
     
139. STASSEN J, Ewe SH, Butcher SC, Amanullah MR, et al
     Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis.
     Heart. 2022 Jun 10. pii: heartjnl-2022-320886. doi: 10.1136/heartjnl-2022-320886
     PubMed     Abstract available
     
     
     
140. KUSUNOSE K
     Is diastolic dysfunction a red flag sign in moderate aortic stenosis?
     Heart. 2022 Jun 10. pii: heartjnl-2022-321137. doi: 10.1136/heartjnl-2022-321137
     PubMed    
     
     
     
141. TANAKA T, Kavsur R, Spieker M, Iliadis C, et al
     Guideline-directed medical therapy after transcatheter edge-to-edge mitral valve repair.
     Heart. 2022 Jun 7. pii: heartjnl-2022-320826. doi: 10.1136/heartjnl-2022-320826.
     PubMed     Abstract available
     
     
     May 2022
142. VOIT J, Otto CM, Burke CR
     Acute native aortic regurgitation: clinical presentation, diagnosis and management.
     Heart. 2022 May 31. pii: heartjnl-2021-320157. doi: 10.1136/heartjnl-2021-320157
     PubMed    
     
     
     
143. BARTON AK, Dweck MR
     Mid-regional pro-adrenomedullin: a new tool in prognosticating asymptomatic severe aortic stenosis?
     Heart. 2022 May 25. pii: heartjnl-2022-321087. doi: 10.1136/heartjnl-2022-321087
     PubMed    
     
     
     
144. NEDADUR R, Belzile D, Farrell A, Tsang W, et al
     Mixed aortic stenosis and regurgitation: a clinical conundrum.
     Heart. 2022 May 24. pii: heartjnl-2021-320501. doi: 10.1136/heartjnl-2021-320501
     PubMed     Abstract available
     
     
     
145. LANGSTON MC, Zack CJ, Fender EA
     Non-bacterial thrombotic endocarditis: manifestations and diagnosis in the age of echocardiography.
     Heart. 2022 May 24. pii: heartjnl-2022-321223. doi: 10.1136/heartjnl-2022-321223
     PubMed    
     
     
     
146. LINDMAN BR, Goel K
     British Societies' recommendations for Heart Team multidisciplinary meetings: broadly relevant principles with anticipated regional differences in process.
     Heart. 2022;108:824-826.
     PubMed    
     
     
     
147. COHEN DJ, Magnuson E, Stone GW, Cleland JGF, et al
     Response to: Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Armoiry and Connock.
     Heart. 2022 May 9. pii: heartjnl-2022-321180. doi: 10.1136/heartjnl-2022-321180.
     PubMed    
     
     
     
148. ARMOIRY X, Connock M
     Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Cohen et al.
     Heart. 2022 May 9. pii: heartjnl-2022-321179. doi: 10.1136/heartjnl-2022-321179.
     PubMed    
     
     
     
149. GARBI M, Mariani A
     Response to: Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Armoiry and Connock.
     Heart. 2022 May 9. pii: heartjnl-2022-321181. doi: 10.1136/heartjnl-2022-321181.
     PubMed    
     
     
     
150. ANDERSON RH
     Correspondence on 'The personalized external aortic root support procedure: interesting niche or ready for prime time?' by Burke et al.
     Heart. 2022;108:744.
     PubMed    
     
     
     
151. DELGADO-ARANA JR, Gordillo-Monge MX, Halim J, De Marco F, et al
     Early clinical and haemodynamic matched comparison of balloon-expandable valves.
     Heart. 2022;108:725-732.
     PubMed     Abstract available
     
     
     
152. DOBSON LE, Prendergast BD
     Heart valve disease: a journey of discovery.
     Heart. 2022;108:774-779.
     PubMed     Abstract available
     
     
     
153. MOODY WE, Elliott PM
     Changing concepts in heart muscle disease: the evolving understanding of hypertrophic cardiomyopathy.
     Heart. 2022;108:768-773.
     PubMed     Abstract available
     
     
     April 2022
154. BERGLER-KLEIN J
     Calcium, vitamin D and aortic valve calcification: to the bone or to the heart?
     Heart. 2022 Apr 25. pii: heartjnl-2021-320672. doi: 10.1136/heartjnl-2021-320672
     PubMed    
     
     
     
155. KASSIS N, Hariri EH, Karrthik AK, Ahuja KR, et al
     Supplemental calcium and vitamin D and long-term mortality in aortic stenosis.
     Heart. 2022 Apr 25. pii: heartjnl-2021-320215. doi: 10.1136/heartjnl-2021-320215
     PubMed     Abstract available
     
     
     
156. SAJI M, Nanasato M
     Transcatheter aortic valve replacement: a gatekeeper for improving global disparities in patients with severe aortic stenosis.
     Heart. 2022 Apr 13. pii: heartjnl-2022-320992. doi: 10.1136/heartjnl-2022-320992
     PubMed    
     
     
     
157. OTTO CM
     Heartbeat: lower risk of infective endocarditis after transcatheter, compared with surgical, aortic valve replacement.
     Heart. 2022;108:579-581.
     PubMed    
     
     
     
158. IUNG B
     Global threat of rheumatic heart disease: do not forget children!
     Heart. 2022;108:582-583.
     PubMed    
     
     
     
159. SCHOON Y
     Shared decision-making is not common in clinical practice.
     Heart. 2022;108:498-499.
     PubMed    
     
     
     March 2022
160. RODRIGUEZ-PALOMARES JF
     Genetics of bicuspid aortic valve: ready for clinical use?
     Heart. 2022 Mar 30. pii: heartjnl-2021-320742. doi: 10.1136/heartjnl-2021-320742
     PubMed    
     
     
     
161. OKUNO T, Tomii D, Buffle E, Lanz J, et al
     Transcatheter aortic valve implantation in patients with rheumatic aortic stenosis.
     Heart. 2022 Mar 29. pii: heartjnl-2021-320531. doi: 10.1136/heartjnl-2021-320531
     PubMed     Abstract available
     
     
     
162. TAN ESJ, Oon YY, Chan SP, Liew OW, et al
     Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis.
     Heart. 2022 Mar 24. pii: heartjnl-2021-320707. doi: 10.1136/heartjnl-2021-320707
     PubMed     Abstract available
     
     
     
163. FRIEDEN P, Blais C, Hamel D, Gamache P, et al
     Evolution of the burden of aortic stenosis by sex in the province of Quebec between 2006 and 2018.
     Heart. 2022 Mar 21. pii: heartjnl-2021-319848. doi: 10.1136/heartjnl-2021-319848
     PubMed     Abstract available
     
     
     
164. DEBIEC RM, Hamby SE, Jones PD, Safwan K, et al
     Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions.
     Heart. 2022 Mar 14. pii: heartjnl-2021-320428. doi: 10.1136/heartjnl-2021-320428
     PubMed     Abstract available
     
     
     
165. SUN BJ, Song JK
     Bicuspid aortic valve: evolving knowledge and new questions.
     Heart. 2022 Mar 9. pii: heartjnl-2021-320008. doi: 10.1136/heartjnl-2021-320008.
     PubMed     Abstract available
     
     
     
166. CHATRATH N, Papadakis M
     Physical activity and exercise recommendations for patients with valvular heart disease.
     Heart. 2022 Mar 2. pii: heartjnl-2021-319824. doi: 10.1136/heartjnl-2021-319824.
     PubMed     Abstract available
     
     
     
167. VOGELHUBER J, Weber M, Nickenig G
     Transcatheter tricuspid intervention: ready for primetime?
     Heart. 2022;108:479-491.
     PubMed    
     
     
     February 2022
168. GARBI M, Mariani A
     Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation: is confirmation needed?
     Heart. 2022 Feb 10. pii: heartjnl-2021-320699. doi: 10.1136/heartjnl-2021-320699
     PubMed    
     
     
     
169. NEDADUR R, Wang B, Tsang W
     Artificial intelligence for the echocardiographic assessment of valvular heart disease.
     Heart. 2022 Feb 10. pii: heartjnl-2021-319725. doi: 10.1136/heartjnl-2021-319725
     PubMed     Abstract available
     
     
     
170. KANG DY, Ahn JM, Kim JB, Yeung A, et al
     Inter-racial differences in patients undergoing transcatheter aortic valve implantation.
     Heart. 2022 Feb 2. pii: heartjnl-2021-320364. doi: 10.1136/heartjnl-2021-320364.
     PubMed     Abstract available
     
     
     January 2022
171. RAISI-ESTABRAGH Z, Bagur R, Mamas MA
     Infective endocarditis in transcatheter and surgical aortic valve prostheses.
     Heart. 2022 Jan 27. pii: heartjnl-2021-320650. doi: 10.1136/heartjnl-2021-320650
     PubMed    
     
     
     
172. KAISER Y, Nurmohamed NS, Stroes ESG, Boekholdt SM, et al
     Response to: Correspondence on "Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis" by Pantelidis et al.
     Heart. 2022 Jan 27. pii: heartjnl-2021-320644. doi: 10.1136/heartjnl-2021-320644
     PubMed    
     
     
     
173. PANTELIDIS P, Oikonomou E
     Correspondence on "Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis" by Kaiser et al.
     Heart. 2022 Jan 27. pii: heartjnl-2021-320643. doi: 10.1136/heartjnl-2021-320643
     PubMed    
     
     
     
174. COHEN DJ, Wang K, Magnuson E, Smith R, et al
     Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation.
     Heart. 2022 Jan 25. pii: heartjnl-2021-320005. doi: 10.1136/heartjnl-2021-320005
     PubMed     Abstract available
     
     
     
175. CAHILL TJ, Raby J, Jewell PD, Brennan PF, et al
     Risk of infective endocarditis after surgical and transcatheter aortic valve replacement.
     Heart. 2022 Jan 20. pii: heartjnl-2021-320080. doi: 10.1136/heartjnl-2021-320080
     PubMed     Abstract available
     
     
     
176. CAMPISI S, Habougit C, Guichard JB
     Acute aortic valve dysfunction in a woman with livedo racemosa and memory impairment.
     Heart. 2022;108:110-156.
     PubMed    
     
     
     
177. VITALE G, Ditaranto R, Graziani F, Tanini I, et al
     Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
     Heart. 2022;108:54-60.
     PubMed     Abstract available
     
     
     December 2021
178. BROWNRIGG JR, Leo V, Rose J, Low E, et al
     Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.
     Heart. 2021 Dec 30. pii: heartjnl-2021-320181. doi: 10.1136/heartjnl-2021-320181
     PubMed     Abstract available
     
     
     
179. GUPTA JI, Gualano SK, Bhave N
     Aortic stenosis in chronic kidney disease: challenges in diagnosis and treatment.
     Heart. 2021 Dec 24. pii: heartjnl-2021-319604. doi: 10.1136/heartjnl-2021-319604
     PubMed     Abstract available
     
     
     
180. VAN BEEK-PEETERS JJAM, van der Meer JBL, Faes MC, de Vos AJBM, et al
     Professionals' views on shared decision-making in severe aortic stenosis.
     Heart. 2021 Dec 24. pii: heartjnl-2021-320194. doi: 10.1136/heartjnl-2021-320194
     PubMed     Abstract available
     
     
     
181. GUO X, Song R, Chen Y
     Severe aortic regurgitation and heart failure.
     Heart. 2021;107:1874-1924.
     PubMed    
     
     
     
182. OTTO CM
     Heartbeat: early intervention for rheumatic mitral stenosis.
     Heart. 2021;107:1925-1927.
     PubMed    
     
     
     
183. SIBILITZ KL, Anayo L, Taylor RS
     Cochrane corner: Exercise-based cardiac rehabilitation for adults after heart valve surgery.
     Heart. 2021;107:1935-1937.
     PubMed    
     
     
     November 2021
184. SORRENTINO R, Santoro C, Bardi L, Rigolin V, et al
     Non-cardiac surgery in patients with valvular heart disease.
     Heart. 2021 Nov 23. pii: heartjnl-2021-319160. doi: 10.1136/heartjnl-2021-319160
     PubMed     Abstract available
     
     
     October 2021
185. CHENG R, Griffin J
     Implications of screening for coexisting transthyretin amyloidosis and aortic stenosis.
     Heart. 2021 Oct 11. pii: heartjnl-2021-320229. doi: 10.1136/heartjnl-2021-320229
     PubMed    
     
     
     
186. KARTHIKEYAN G
     Early intervention for asymptomatic mitral stenosis: a stitch in time?
     Heart. 2021 Oct 7. pii: heartjnl-2021-319987. doi: 10.1136/heartjnl-2021-319987.
     PubMed    
     
     
     
187. CHAN KL
     Lipoprotein(a) and aortic stenosis.
     Heart. 2021 Oct 5. pii: heartjnl-2021-320173. doi: 10.1136/heartjnl-2021-320173.
     PubMed    
     
     
     
188. KNIGHT JH, Sarvestani AL, Ibezim C, Turk E, et al
     Multicentre comparative analysis of long-term outcomes after aortic valve replacement in children.
     Heart. 2021 Oct 5. pii: heartjnl-2021-319597. doi: 10.1136/heartjnl-2021-319597.
     PubMed     Abstract available
     
     
     
189. WU G, Liu J, Wang S, Yu S, et al
     N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
     Heart. 2021;107:1576-1583.
     PubMed     Abstract available
     
     
     September 2021
190. KAISER Y, Nurmohamed NS, Kroon J, Verberne HJ, et al
     Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis.
     Heart. 2021 Sep 30. pii: heartjnl-2021-319804. doi: 10.1136/heartjnl-2021-319804
     PubMed     Abstract available
     
     
     
191. LIM MS, Cordina R, Kotchetkova I, Celermajer DS, et al
     Late complication rates after aortic coarctation repair in patients with or without a bicuspid aortic valve.
     Heart. 2021 Sep 17. pii: heartjnl-2021-319969. doi: 10.1136/heartjnl-2021-319969
     PubMed     Abstract available
     
     
     
192. KANG DH, Park SJ, Lee SA, Lee S, et al
     Early percutaneous mitral commissurotomy or conventional management for asymptomatic mitral stenosis: a randomised clinical trial.
     Heart. 2021 Sep 15. pii: heartjnl-2021-319857. doi: 10.1136/heartjnl-2021-319857
     PubMed     Abstract available
     
     
     
193. PATEL KP, Scully PR, Nitsche C, Kammerlander AA, et al
     Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.
     Heart. 2021 Sep 8. pii: heartjnl-2021-319922. doi: 10.1136/heartjnl-2021-319922.
     PubMed     Abstract available
     
     
     
194. OTTO CM
     Heartbeat: prevalence and treatment of severe aortic stenosis in older patients.
     Heart. 2021;107:1439-1441.
     PubMed    
     
     
     August 2021
195. STEWART S, Chan YK, Playford D, Strange GA, et al
     Incident aortic stenosis in 49 449 men and 42 229 women investigated with routine echocardiography.
     Heart. 2021 Aug 25. pii: heartjnl-2021-319697. doi: 10.1136/heartjnl-2021-319697
     PubMed     Abstract available
     
     
     
196. WILLIAMS MC, Dweck MR
     Cardiovascular risk factors and aortic valve calcification: what do these associations mean?
     Heart. 2021 Aug 10. pii: heartjnl-2021-319688. doi: 10.1136/heartjnl-2021-319688
     PubMed    
     
     
     
197. KHURRAMI L, Moller JE, Lindholt JS, Urbonaviciene G, et al
     Cross-sectional study of aortic valve calcification and cardiovascular risk factors in older Danish men.
     Heart. 2021 Aug 10. pii: heartjnl-2021-319023. doi: 10.1136/heartjnl-2021-319023
     PubMed     Abstract available
     
     
     
198. IUNG B, Bouleti C
     Adverse cardiovascular disease outcomes in patients with aortic sclerosis and mitral annular calcification even when valve function is normal.
     Heart. 2021;107:1280-1281.
     PubMed    
     
     
     June 2021
199. DEFERM S, Bertrand PB, Verhaert D, Dauw J, et al
     Outcome and durability of mitral valve annuloplasty in atrial secondary mitral regurgitation.
     Heart. 2021 Jun 15. pii: heartjnl-2021-319045. doi: 10.1136/heartjnl-2021-319045
     PubMed     Abstract available
     
     
     
200. SAITO C, Minami Y, Hagiwara N
     Treatment options for the management of atrial functional mitral regurgitation.
     Heart. 2021 Jun 15. pii: heartjnl-2021-319470. doi: 10.1136/heartjnl-2021-319470
     PubMed    
     
     
     
201. IUNG B, Arangalage D
     Community burden of aortic valve disease.
     Heart. 2021 Jun 14. pii: heartjnl-2021-319560. doi: 10.1136/heartjnl-2021-319560
     PubMed    
     
     
     
202. LAMELAS P, Ragusa MA, Bagur R, Jaffer I, et al
     Clinical practice guideline for transcatheter versus surgical valve replacement in patients with severe aortic stenosis in Latin America.
     Heart. 2021 Jun 14. pii: heartjnl-2021-319489. doi: 10.1136/heartjnl-2021-319489
     PubMed     Abstract available
     
     
     
203. OWENS DS, Bartz TM, Buzkova P, Massera D, et al
     Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults.
     Heart. 2021 Jun 2. pii: heartjnl-2021-319025. doi: 10.1136/heartjnl-2021-319025.
     PubMed     Abstract available
     
     
     May 2021
204. TAYLOR CJ, Ordonez-Mena JM, Jones NR, Roalfe AK, et al
     Survival of people with valvular heart disease in a large, English community-based cohort study.
     Heart. 2021 May 24. pii: heartjnl-2020-318823. doi: 10.1136/heartjnl-2020-318823
     PubMed     Abstract available
     
     
     
205. TZOLOS E, Dweck MR
     Threshold effect for lipoprotein(a) in aortic stenosis.
     Heart. 2021 May 21. pii: heartjnl-2021-319376. doi: 10.1136/heartjnl-2021-319376
     PubMed    
     
     
     
206. ERHART L, Donati T, Anwer S, Schindler M, et al
     Left ventricular twist predicts mortality in severe aortic stenosis.
     Heart. 2021 May 10. pii: heartjnl-2020-318800. doi: 10.1136/heartjnl-2020-318800
     PubMed     Abstract available
     
     
     
207. KAISER Y, Singh SS, Zheng KH, Verbeek R, et al
     Lipoprotein(a) is robustly associated with aortic valve calcium.
     Heart. 2021 May 7. pii: heartjnl-2021-319044. doi: 10.1136/heartjnl-2021-319044.
     PubMed     Abstract available
     
     
     
208. 
     Correction: Determinants of clinical outcomes of surgery for isolated severe tricuspid regurgitation.
     Heart. 2021;107:e4.
     PubMed    
     
     
     
209. KARTHIKEYAN G
     Stroke risk in rheumatic heart disease.
     Heart. 2021;107:694-696.
     PubMed    
     
     
     April 2021
210. HUDED CP, Allen KB, Chhatriwalla AK
     Counterpoint: challenges and limitations of transcatheter aortic valve implantation for aortic regurgitation.
     Heart. 2021 Apr 16. pii: heartjnl-2020-318682. doi: 10.1136/heartjnl-2020-318682
     PubMed     Abstract available
     
     
     
211. KHAN SA, Baron SJ
     Point: patients with native aortic regurgitation can be treated with transcatheter aortic valve implantation.
     Heart. 2021 Apr 16. pii: heartjnl-2021-319179. doi: 10.1136/heartjnl-2021-319179
     PubMed     Abstract available
     
     
     
212. BUTCHER SC, Fortuni F, Kong W, Vollema EM, et al
     Prognostic implications of left atrial dilation in aortic regurgitation due to bicuspid aortic valve.
     Heart. 2021 Apr 8. pii: heartjnl-2020-318907. doi: 10.1136/heartjnl-2020-318907.
     PubMed     Abstract available
     
     
     
213. JAHANGIRI M
     Survival after surgical aortic valve replacement in patients with bicuspid aortic valve disease.
     Heart. 2021 Apr 1. pii: heartjnl-2021-319088. doi: 10.1136/heartjnl-2021-319088.
     PubMed    
     
     
     
214. YEOH J, MacCarthy P
     Is it time to refresh the heart team? New paradigms for shared decision making.
     Heart. 2021;107:674-681.
     PubMed    
     
     
     March 2021
215. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
     Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
     Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
     PubMed     Abstract available
     
     
     
216. CAHILL TJ, Prothero A, Wilson J, Kennedy A, et al
     Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation.
     Heart. 2021 Mar 4. pii: heartjnl-2020-318482. doi: 10.1136/heartjnl-2020-318482.
     PubMed     Abstract available
     
     
     
217. BONGIOVANNI D, Presbitero P
     Does radial balloon aortic valvuloplasty have a place in the TAVI era?
     Heart. 2021 Mar 3. pii: heartjnl-2021-318997. doi: 10.1136/heartjnl-2021-318997.
     PubMed    
     
     
     
218. OTTO CM
     Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular disease.
     Heart. 2021;107:345-347.
     PubMed    
     
     
     February 2021
219. TUMSCITZ C, Di Cesare A, Balducelli M, Piva T, et al
     Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty.
     Heart. 2021 Feb 24. pii: heartjnl-2020-318548. doi: 10.1136/heartjnl-2020-318548
     PubMed     Abstract available
     
     
     
220. ANDO T, Ashraf S, Kuno T, Briasoulis A, et al
     Hospital variation of 30-day readmission rate following transcatheter aortic valve implantation.
     Heart. 2021 Feb 24. pii: heartjnl-2020-318583. doi: 10.1136/heartjnl-2020-318583
     PubMed     Abstract available
     
     
     
221. GLASER N, Jackson V, Eriksson P, Sartipy U, et al
     Relative survival after aortic valve surgery in patients with bicuspid aortic valves.
     Heart. 2021 Feb 23. pii: heartjnl-2020-318733. doi: 10.1136/heartjnl-2020-318733
     PubMed     Abstract available
     
     
     
222. HEEN AF, Lytvyn L, Shapiro M, Guyatt GH, et al
     Patient values and preferences on valve replacement for aortic stenosis: a systematic review.
     Heart. 2021 Feb 9. pii: heartjnl-2020-318334. doi: 10.1136/heartjnl-2020-318334.
     PubMed     Abstract available
     
     
     
223. KARSENTY C, Khraiche D, Jais JP, Raimondi F, et al
     Predictors of low exercise cardiac output in patients with severe pulmonic regurgitation.
     Heart. 2021;107:223-228.
     PubMed     Abstract available
     
     
     
224. AHLUWALIA M, Ho CY
     Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy.
     Heart. 2021;107:183-189.
     PubMed     Abstract available
     
     
     January 2021
225. CARTLIDGE TR, Bing R, Kwiecinski J, Guzzetti E, et al
     Contrast-enhanced computed tomography assessment of aortic stenosis.
     Heart. 2021 Jan 29. pii: heartjnl-2020-318556. doi: 10.1136/heartjnl-2020-318556
     PubMed     Abstract available
     
     
     
226. LU FL, An Z, Ma Y, Song ZG, et al
     Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation.
     Heart. 2021 Jan 8. pii: heartjnl-2020-318199. doi: 10.1136/heartjnl-2020-318199.
     PubMed     Abstract available
     
     
     December 2020
227. KITANO T, Nabeshima Y, Negishi K, Takeuchi M, et al
     Prognostic value of automated longitudinal strain measurements in asymptomatic aortic stenosis.
     Heart. 2020 Dec 14. pii: heartjnl-2020-318256. doi: 10.1136/heartjnl-2020-318256
     PubMed     Abstract available
     
     
     
228. OTTO CM
     Heartbeat: is medical therapy for calcific aortic stenosis possible?
     Heart. 2020;106:1783-1785.
     PubMed    
     
     
     November 2020
229. CIPRIANI A, Bauce B
     Ventricular arrhythmias in mitral valve prolapse: new explanations for an old problem.
     Heart. 2020 Nov 25. pii: heartjnl-2020-318086. doi: 10.1136/heartjnl-2020-318086
     PubMed    
     
     
     
230. GRAYBURN PA, Packer M, Sannino A, Stone GW, et al
     Disproportionate secondary mitral regurgitation: myths, misconceptions and clinical implications.
     Heart. 2020 Nov 24. pii: heartjnl-2020-316992. doi: 10.1136/heartjnl-2020-316992
     PubMed     Abstract available
     
     
     
231. REDDY YNV, Alkhouli M, Nishimura RA
     Isolated severe tricuspid regurgitation: an unrecognised and undertreated problem of the forgotten valve.
     Heart. 2020 Nov 24. pii: heartjnl-2020-318399. doi: 10.1136/heartjnl-2020-318399
     PubMed    
     
     
     
232. BAKER DW, Celermajer DS
     Would increasing stress on the heart decrease stress on the doctor? Decision-making in asymptomatic pulmonary regurgitation.
     Heart. 2020 Nov 20. pii: heartjnl-2020-318349. doi: 10.1136/heartjnl-2020-318349
     PubMed    
     
     
     
233. BING R, Dweck MR
     Management of asymptomatic severe aortic stenosis: check or all in?
     Heart. 2020 Nov 4. pii: heartjnl-2020-317160. doi: 10.1136/heartjnl-2020-317160.
     PubMed    
     
     
     
234. PARK SJ, Oh JK, Kim SO, Lee SA, et al
     Determinants of clinical outcomes of surgery for isolated severe tricuspid regurgitation.
     Heart. 2020 Nov 2. pii: heartjnl-2020-317715. doi: 10.1136/heartjnl-2020-317715.
     PubMed     Abstract available
     
     
     
235. OTTO CM
     Heartbeat: time to treat the whole patient, not just the valve, when calcific aortic stenosis is present.
     Heart. 2020;106:1621-1623.
     PubMed    
     
     
     October 2020
236. EGBE A, Miranda W, Connolly H, Dearani J, et al
     Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly.
     Heart. 2020 Oct 29. pii: heartjnl-2020-317756. doi: 10.1136/heartjnl-2020-317756
     PubMed     Abstract available
     
     
     
237. YANG LT, Benfari G, Eleid M, Scott CG, et al
     Contemporary differences between bicuspid and tricuspid aortic valve in chronic aortic regurgitation.
     Heart. 2020 Oct 27. pii: heartjnl-2020-317466. doi: 10.1136/heartjnl-2020-317466
     PubMed     Abstract available
     
     
     
238. GUZZETTI E, Clavel MA
     Measuring progression of aortic stenosis: computed tomography versus echocardiography.
     Heart. 2020 Oct 9. pii: heartjnl-2020-317340. doi: 10.1136/heartjnl-2020-317340.
     PubMed    
     
     
     
239. DORIS MK, Jenkins W, Robson P, Pawade T, et al
     Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression.
     Heart. 2020 Oct 5. pii: heartjnl-2020-317125. doi: 10.1136/heartjnl-2020-317125.
     PubMed     Abstract available
     
     
     
240. VAN WIJNGAARDEN AL, de Riva M, Hiemstra YL, van der Bijl P, et al
     Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation.
     Heart. 2020 Oct 1. pii: heartjnl-2020-317451. doi: 10.1136/heartjnl-2020-317451.
     PubMed     Abstract available
     
     
     
241. SHAH BN, Schlosshan D, McConkey HZR, Buch MH, et al
     Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care.
     Heart. 2020;106:1549-1554.
     PubMed     Abstract available
     
     
     
242. PFIRMAN KS, Dawson Dowe J, Gaba D
     Man in his 70s with fatigue, dyspnoea and recurrent atrial fibrillation.
     Heart. 2020;106:1572-1619.
     PubMed    
     
     
     September 2020
243. HAUGAA K
     Improving the imaging diagnosis of mitral annular disjunction.
     Heart. 2020 Sep 14. pii: heartjnl-2020-317667. doi: 10.1136/heartjnl-2020-317667
     PubMed    
     
     
     July 2020
244. OTTO CM
     Heartbeat: Rapid rule-out pathways for acute myocardial infarction.
     Heart. 2020;106:951-953.
     PubMed    
     
     
     June 2020
245. CAMAIONI C, Knott KD, Augusto JB, Seraphim A, et al
     Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
     Heart. 2020;106:824-829.
     PubMed     Abstract available
     
     
     May 2020
246. RAMCHAND J, Fava AM, Chetrit M, Desai MY, et al
     Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy.
     Heart. 2020 May 25. pii: heartjnl-2020-316770. doi: 10.1136/heartjnl-2020-316770
     PubMed    
     
     
     
247. FANG Q, Zhang Y, Gu T
     66-year-old man with an intriguing intracardiac mass.
     Heart. 2020;106:723-784.
     PubMed    
     
     
     April 2020
248. DUCAS RA, Javier DA, D'Souza R, Silversides CK, et al
     Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis.
     Heart. 2020;106:512-519.
     PubMed     Abstract available
     
     
     March 2020
249. VESELKA J, Jensen M, Liebregts M, Cooper RM, et al
     Alcohol septal ablation in patients with severe septal hypertrophy.
     Heart. 2020;106:462-466.
     PubMed     Abstract available
     
     
     January 2020
250. RAMCHAND J, Fava AM, Chetrit M, Desai MY, et al
     Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy.
     Heart. 2020 Jan 16. pii: heartjnl-2019-315176. doi: 10.1136/heartjnl-2019-315176
     PubMed     Abstract available
     
     
     December 2019
251. OSTERGAARD L, Dahl A, Bruun NE, Oestergaard LB, et al
     Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure.
     Heart. 2019 Dec 10. pii: heartjnl-2019-315715. doi: 10.1136/heartjnl-2019-315715
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.